CAS 104340-86-5: Leminoprazole

Description:Leminoprazole is a proton pump inhibitor (PPI) that is primarily used to reduce gastric acid secretion. It functions by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of the gastric parietal cells, thereby decreasing the production of stomach acid. This mechanism makes it effective in treating conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. Leminoprazole is characterized by its ability to provide long-lasting acid suppression, which can promote healing of the gastrointestinal mucosa. The compound is typically administered orally and is known for its favorable pharmacokinetic profile, including good bioavailability and a relatively short half-life, necessitating once-daily dosing in most cases. Additionally, it may exhibit a range of side effects, including gastrointestinal disturbances and potential interactions with other medications. As with other PPIs, long-term use may be associated with risks such as vitamin B12 deficiency and increased susceptibility to certain infections.

Formula:C₁₉H₂₃N₃OS

InChI:InChI=1/C19H23N3OS/c1-14(2)12-22(3)18-11-7-4-8-15(18)13-24(23)19-20-16-9-5-6-10-17(16)21-19/h4-11,14H,12-13H2,1-3H3,(H,20,21)